David E Isenman

Title: David E Isenman: Innovator in Pharmaceutical Composition

Introduction

David E Isenman is a notable inventor based in Toronto, Canada. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of inflammatory conditions. With a total of 2 patents, his work has the potential to impact various medical applications.

Latest Patents

One of Isenman's latest patents focuses on the use of complement split product C4d for treating inflammatory conditions. This invention relates to a pharmaceutical composition that can be utilized in cases such as graft rejection, graft versus host disease, autoimmune diseases, or atopy. The patent emphasizes the use of C4d multimers and their applications in medicine. Additionally, it introduces a protein complex comprising C4d interacting with its ILT4 receptor, which may be beneficial in screening methods. The invention also covers antibodies that specifically bind to the C4d multimer or the C4d/ILT4-protein complex.

Career Highlights

David E Isenman is affiliated with the Medical University of Vienna, where he continues to advance his research and innovations. His work in the pharmaceutical field has garnered attention for its potential to address significant health challenges.

Collaborations

Isenman has collaborated with notable colleagues such as Johannes Hofer and Judith Leitner. These partnerships have contributed to the development and refinement of his innovative ideas.

Conclusion

David E Isenman stands out as an influential inventor in the pharmaceutical industry, with a focus on innovative treatments for inflammatory conditions. His contributions through patents and collaborations highlight his commitment to advancing medical science.